Alex Jannan

Person

Pharmaceutical industry reporter covering drug development, clinical studies, and major pharmaceutical companies for The Wall Street Journal. In the excerpt, Jannan reports on Eli Lilly’s study of a combination weight-loss treatment compared with Zepbound alone.